Th1- and th2-type cytokines regulate the expression and production of eotaxin and rantes by human lung fibroblasts

American Journal of Respiratory Cell and Molecular Biology

Volumn 20, Issue 4, 1999, Pages 777-786

  Teran, Luis M ^a   Mochizuki, Mitsuru ^b   Bartels, Joachim ^b   Valencia, Elba L ^b   Nakajima, Toshiharu ^b   Hirai, Koichi ^b   Schröder, Jens M ^b  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EOS;

BETA CHEMOKINE; CYTOKINE; EOSINOPHIL CHEMOTACTIC FACTOR; EOTAXIN; GAMMA INTERFERON; INTERLEUKIN 4; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHEMOTAXIS; DRUG EFFECT; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; KINETICS; LUNG; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH2 CELL;

CELLS, CULTURED; CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; CHEMOTAXIS; CYTOKINES; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; KINETICS; LUNG; RANTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033112651     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.20.4.3508     Document Type: Article

References (38)

1. Davies, W. B., G. A. Fells, X. H. Sun, J. E. Gadek, A. Venet, and R. G. Crystal. 1984. Eosinophil mediated injury to lung parenchymal cells and interstitial matrix: a possible rule for eosinophils in chronic inflammatory disorders of the lower respiratory tract. J. Clin. Invest. 74:269-278.
2. Zhang, K., M. Gharaee-Kermani, B. McGarry, D. Remick, and S. H. Phan. 1997. TNF-α-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis. J. Immunol. 158:954-959.
3. Peterson, M. W., M. Monick, and G. W. Hunninghake. 1987. Prognostic role of eosinophils in pulmonary fibrosis. Chest 92:51-56.
4. Hållgren, R., L. Bjermer, R. Lundgfen, and P. Venge. 1989. The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis: signs of eosinophil activation in the lung are related to impaired lung function. Am. Rev. Respir. Dis. 139:373-377.
5. Roche, W. R., J. H. Williams, C. R. W. Beasley, and S. T. Holgate. 1989. Subepithelial fibrosis in the bronchi of asthmatics. Lancet i:520-524.
6. Martin, L. B., H. Kita, K. M. Leiferman, and G. J. Gleich. 1996. Eosinophils in allergy: role in disease, degranulation, and cytokine. Int. Arch. Allergy Immunol. 109:207-215.
7. Rubbia-Brandt, L., A. Sappino, and G. Gabbiani. 1991. Locally applied GM-CSF induces the accumulation of α-smooth muscle actin containing fibroblasts. Virchows Arch. 60:73-82.
8. Finotlo, S., I. Ohno, J. S. Marshall, J. Gauldie, J. A. Denburg, J. Dolovich, D. A. Clark, and M. Jordana. 1994. TNF-α production by eosinophils in upper airways inflammation (nasal polyposis). J. Immunol. 153:2278-2289.
9. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
10. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more, Immunol. Today 17:138-146.
11. + T lymphocytes in atopic subjects. J. Immunol. 144:4651-4656.
12. Parronchi, P., D. Macchia, M. P. Piccini, P. Biswas, C. Simonelli, E. Maggi, M. Ricci, A. A. Ansari, and S. Romagnani. 1991. Allergen-and bacterial antigen-specific T cell clones established from atopic donors show a different profile of cytokine production. Proc. Natl. Acad. Sci. USA 88:4538-4542.
13. Romagnani, S. 1996. Development of Th1-or Th2-dominated immuno responses: what about the polarizing signals? Int. Clin. Lab. Res. 26:83-98.
14. Lukacs, N. W., C. L. Addison, J. Gauldie, F. Graham, K. Simpson, R. M. Stricter, K. Warmington, S. W. Chensue, and S. L. Kunkel. 1997. Transgene-induced production of IL-4 alters the development and collagen expression of T helper cell 1-type pulmonary granulomas. J. Immunol. 158: 4478-4484.
15. Mueller, R., T. Krahl, and N. Sarvetnick. 1997. Tissue-specific expression of interleukin-4 induces extracellular matrix accumulation and extravasation of B cells. Lab. Invest. 76:117-128.
16. Wallace, W. A., E. A. Ramage, D. Lamb, and S. E. Howie. 1995. A type 2 (Th2-like) pattern of immune response predominates in the pulmonary in-terstitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin. Exp. Immunol. 101:436-441.
17. Sempowski, G. D., S. Derdak, and R. P. Phipps. 1996. Interleukin-4 and interferon-gamma discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets. J. Cell Physiol. 167:290-296.
18. Mochizuki, M., J. Bartels, A. I. Mallet, E. Christophers, and J.-M. Schröder. 1988. IL-4 induces eotaxin: a possible mechanism of eosinophil recruitment in helminth infection and atopy. J. Immunol. 160:60-68.
19. Teran, L. M., and D. E. Davies. 1996. The chemokines: their potential role in allergic inflammation. Clin. Exp. Allergy 126:1005-1019.
20. Schröder, J., and E. Christophers. 1987. Purification and partial biochemical characterization of a human monocyte-derived neutrophil-activating peptide that lacks interleukin-1 activity. J. Immunol. 139:3474-3483.
21. Teran, L. M., N. Noso, M. P. Carroll, D. E. Davies, S. T. Holgate, and J. Schröder. 1996. Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES in asthmatic airways. J. Immunol. 157:1806-1812.
22. Sticherling, M., M. Kupper, F. Koltrowitz, E. Bornscheuer, R. Kulke, M. Klinger, D. Wilhelm, Y. Kameyoshi, E. Christophers, and J. Schröder. 1995. Detection of chemokine RANTES in cytokine-stimulated human dermal fibroblasts. J. Invest. Dermatol. 105:585-591.
23. Bartels, J., C. Schluter, E. Richter, N. Noso, R. Kulke, E. Christophers, and J. M. Schröder. 1996. Human dermal fibroblasts express eotaxin: molecular cloning, mRNA expression, and identification of eotaxin sequence variants. Biochem. Biophys. Res. Commun. 225:1045-1051.
24. O'Garra, A., and K. Murphy. 1996. Role of cytokines in development of Th1 and Th2 cells. Chem. Immunol. 63:1-13.
25. Mould, A. W., K. I. Matthaei, I. O. Young, and P. S. Foster. 1997. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J. Clin. Invest. 99:1064-1071.
26. Palframan, R. T., P. D. Collins, T. J. Williams, and S. M. Rankin. 1998. Eotaxin induces a rapid release of eosnophils and their progenitors from the bone marrow. Blood 91:2240-2248.
27. Heath, H., S. Qin, P. Rao, L. Wu, G. LaRosa, N. Kassam, P. D. Ponath, and C. R. MacKay. 1997. Chemokine receptor usage by human cosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J. Clin. Invest. 99:178-184.
28. Lamkhioued, B., P. M. Renzi, S. Abi-Younes, A. Garcia-Zepeda, Z. Allakhverdi, O. Ghaffar, M. D. Rothenberg, A. D. Luster, and Q. Hamid. 1997. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J. Immunol. 159:4593-4601.
29. Garcia-Zepeda, E. A., M. E. Rothenberg, R. T. Ownbey, J. Celestin, P. Leder, and A. D. Luster. 1996. Human eotaxin is an eosinophil selective chemoattractant that provides a new mechanism to explain tissue eosinophilia. Nat. Med. 2:449-456.
30. Stellato, C., P. Collins, P. D. Ponath, D. Soler, W. Newman, G. La Rosa, H. Li, J. White, L. M. Schwiebert, C. Bickel, M. Liu, B. S. Bochner, T. Williams, and R. P. Schleimer. 1997. Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J. Clin. Invest. 99:926-936.
31. Lilly, C. M., H. Nakamura, H. Kesselman, C. Nagler-Anderson, K. Asano, E. A. Garcia-Zepeda, M. F. Rothenberg, J. M. Drazen, and A. D. Luster. 1997. Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J. Clin. Invest. 99:1767-1773.
32. 4 integrin/vascular cell adhesion molecule-1 adhesion pathways. Blood 90:4144-4152.
33. Marfaing-Koka, A., O. Devergene, G. Gorgone, A. Portier, T. J. Schall, P. Galanaud, and D. Emilie. 1995. Regulation of the production of the RANTES chemokine by endothelial cells: synergistic induction by IFN-gamma plus TNF-α and inhibition by IL-4 and IL-13. J. Immunol. 154: 1870-1878.
34. Chensue, S. W., K. Warmington, J. H. Ruth, N. Lukacs, and S. L. Kunkel. 1997. Mycobacterial and schistosomal antigen-elicited granuloma formation in TFN-γ and IL-4 knockout mice. J. Immunol. 159:3565-3573.
35. Robinson, O. S., O. Hamid, S. Ying, A. Tsicopous, J. Barkans, A. M. Bentley, C. J. Corrigan, S. R. Durham, and A. B. Kay. 1992. Evidence for a predominant Th2 type bronchoalveolar lavage T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.
36. Holgate, S. T., K. S. Bodey, A. Janezic, A. J. Flew, A. P. Kaplan, and L. M. Teran. 1997. Release of RANTES, MIP-1α, and MCP-I into asthmatic airways following endobronchial allergen challenge. Am. J. Respir. Crit. Care Med. 156:1377-1383.
37. Humbert, M., S. Ying, C. Corrigan, G. Menz, J. Barkans, R. Pfister, Q. Meng, J. Van Damme, G. Opdenakker, S. R. Durham, and A. B. Kay. 1997. Bronchial mucosal expression of genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3. Am. J. Respir. Cell Mol. Biol. 16:1-8.
38. Bolster, M. B., A. Ludwicka, S. F. Sutherland, C. Strange, and R. M. Silver. 1997. Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis. Arhritis Rheum. 40:743-751.